Presenter: Dr. Stephen Field, University of Calgary
Moderator: Dr. Imran Satia, McMaster University
Chronic cough is the most common complaint in general practice and accounts for up to 40% of referrals to respirologists. Most will respond to anatomic-based approach but approximately a third are refractory to this strategy. Speech therapy techniques are effective in half of these refractory cases. Others may respond to gabapentin or pregabalin but unfortunately, side effects are common. Several medications that target vagal afferent pathways look promising as treatment options and will be discussed.
At the end of this presentation, attendees will be able to:
- Appreciate the burden of chronic cough
- Define and manage chronic refractory cough
- Discuss new treatments on the horizon
CanMEDs Competencies Addressed
This session is co-developed by the Canadian Thoracic Society and Merck and is planned to achieve scientific integrity, objectivity and balance.